Sampling: How to select participants in my research study?

Anais Brasileiros de Dermatologia

Volumn 91, Issue 3, 2016, Pages 326-330

  Martínez Mesa, Jeovany ^a   González Chica, David Alejandro ^b   Duquia, Rodrigo Pereira ^c   Bonamigo, Renan Rangel ^c   Bastos, João Luiz ^d  

^a FACULDADE MERIDIONAL IMED   (Brazil)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Dermatology; Epidemiologic studies; Epidemiology and biostatistics; Sample size; Sampling studies

Indexed keywords

BIOSTATISTICS; DERMATOLOGY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MEDICAL RESEARCH; SAMPLE SIZE; EPIDEMIOLOGY; INFORMATION PROCESSING; PATIENT SELECTION; SELECTION BIAS; STANDARDS;

DATA COLLECTION; HUMANS; PATIENT SELECTION; SAMPLE SIZE; SAMPLING STUDIES; SELECTION BIAS;

EID: 84978378806     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20165254     Document Type: Article

References (15)

1. Martínez-Mesa J, González-Chica DA, Bastos JL, Bonamigo RR, Duquia RP. Sample size: how many participants do I need in my research? An Bras Dermatol. 2014;89: 609-15.
2. Röhrig B, du Prel JB, Wachtlin D, Kwiecien R, Blettner M. Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2010;107: 552-6.
3. Suresh K, Thomas SV, Suresh G. Design, data analysis and sampling techniques for clinical research. Ann Indian Acad Neurol. 2011;14: 287-90.
4. Rothman KJ, Gallacher JE, Hatch EE. Why representativeness should be avoided. Int J Epidemiol. 2013;42: 1012-4.
5. Krause M, Lutz W, Boehnke JR. The role of sampling in clinical trial design. Psychother Res. 2011;21: 243-51.
6. Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. J Rheumatol. 2015;42: 1767-80.
7. Larkin J, Ascierto PA, Dréno B, Atkinson V, Liszkay G, Maio M, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med. 2014;371: 1867-76.
8. Goncalves JR, Nappo SA. Factors that lead to the use of crack cocaine in combination with marijuana in Brazil: a qualitative study. BMC Public Health. 2015;15: 706.
9. Pimenta FB, Pinho L, Silveira MF, Botelho AC. Factors associated with chronic diseases among the elderly receiving treatment under the Family Health Strategy. Cien Saude Colet. 2015;20: 2489-98.
10. Kelbore AG, Alemu W, Shumye A, Getachew S. Magnitude and associated factors of Atopic dermatitis among children in Ayder referral hospital, Mekelle, Ethiopia. BMC Dermatol. 2015;15: 15.
11. Zhou SJ, Skeaff M, Makrides M, Gibson R. Vitamin D status and its predictors among pre-school children in Adelaide. J Paediatr Child Health. 2015;51: 614-9.
12. Duquia RP, Menezes AM, Almeida HL Jr, Reichert FF, Santos Ida S, Haack RL, et al. Prevalence of sun exposure and its associated factors in southern Brazil: a population-based study. An Bras Dermatol. 2013;88: 554-61.
13. Barrios CH, Werutsky G, Martinez-Mesa J. The global conduct of cancer clinical trials: challenges and opportunities. Am Soc Clin Oncol Educ Book. 2015: e132-9.
14. Victora CG, Barros FC. Cohort profile: the 1982 Pelotas (Brazil) birth cohort study. Int J Epidemiol. 2006;35: 237-42.
15. Boing AC, Peres KG, Boing AF, Hallal PC, Silva NN, Peres MA. EpiFloripa Health Survey: the methodological and operational aspects behind the scenes. Rev Bras Epidemiol. 2014;17: 147-62.